Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells
- PMID: 8360493
Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells
Abstract
Highly conserved DBP (human DBP is known as Gc) of serum alpha 2-globulin fraction can be converted to a potent macrophage activating factor by stepwise modification of Gc glycoprotein with beta-galactosidase of B cells and sialidase of T cells. These glycosidases, beta-galactosidase and sialidase, are membrane bound and not soluble in culture medium. Thus, consecutive contact of Gc protein with B cells and T cells, presumably via specific receptors, is required for conversion of Gc glycoprotein to the macrophage activating factor. The essential role of T cell sialidase in macrophage activation was confirmed by the finding that peritoneal nonadherent cells of SM/J mouse, whose T cells are deficient in sialidase activity, were unable to convert Gc protein to the macrophage activating factor and thus did not activate macrophages. Treatment with sialidase of a conditioned medium of lipid metabolite-treated SM/J mouse nonadherent cells efficiently generated the macrophage activating factor. When Gc protein was first treated with soluble or immobilized sialidase and used in a medium for 2 h cultivation of lipid metabolite-treated SM/J mouse nonadherent cells or BALB/c mouse B cells, the resultant conditioned media contained a large amount of the macrophage activating factor. These results support the hypothesis that Gc protein carries a dibranched trisaccharide with galactose and sialic acid termini.
Similar articles
-
Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.Cell Immunol. 1996 Jun 15;170(2):161-7. doi: 10.1006/cimm.1996.0148. Cell Immunol. 1996. PMID: 8660814
-
Role of vitamin D3-binding protein in activation of mouse macrophages.J Immunol. 1996 Aug 15;157(4):1744-9. J Immunol. 1996. PMID: 8759764
-
Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.Immunology. 1991 Nov;74(3):420-4. Immunology. 1991. PMID: 1769691 Free PMC article.
-
Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity.Anticancer Res. 2005 Nov-Dec;25(6A):3689-95. Anticancer Res. 2005. PMID: 16302727 Review.
-
Behind the scenes of vitamin D binding protein: more than vitamin D binding.Best Pract Res Clin Endocrinol Metab. 2015 Oct;29(5):773-86. doi: 10.1016/j.beem.2015.06.006. Epub 2015 Jul 2. Best Pract Res Clin Endocrinol Metab. 2015. PMID: 26522461 Review.
Cited by
-
Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.Cancer Prev Res (Phila). 2016 Aug;9(8):664-72. doi: 10.1158/1940-6207.CAPR-16-0053. Epub 2016 May 31. Cancer Prev Res (Phila). 2016. PMID: 27246684 Free PMC article.
-
Glycosylation status of vitamin D binding protein in cancer patients.Protein Sci. 2009 Oct;18(10):2036-42. doi: 10.1002/pro.214. Protein Sci. 2009. PMID: 19642159 Free PMC article.
-
Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.Cancer Immunol Immunother. 2008 Jul;57(7):1007-16. doi: 10.1007/s00262-007-0431-z. Cancer Immunol Immunother. 2008. Retraction in: Cancer Immunol Immunother. 2014 Dec;63(12):1349. doi: 10.1007/s00262-014-1616-x. PMID: 18058096 Free PMC article. Retracted.
-
Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity.Int J Mol Sci. 2022 Jul 22;23(15):8075. doi: 10.3390/ijms23158075. Int J Mol Sci. 2022. PMID: 35897653 Free PMC article.
-
Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.BMC Cancer. 2018 Feb 6;18(1):155. doi: 10.1186/s12885-018-4026-1. BMC Cancer. 2018. PMID: 29409465 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous